reiterateEXPEfinnhub
Wedbush Reiterates Outperform Rating on Expedia Group, Inc. (EXPE)
Wedbush reiterated its Outperform rating on Expedia Group, Inc. (NASDAQ:EXPE) on August 20, 2026.
Read moreFeatured By
Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Wedbush reiterated its Outperform rating on Expedia Group, Inc. (NASDAQ:EXPE) on August 20, 2026.
Read moreOptimi Health (NASDAQ:OPTH) reported quarterly earnings results on August 14, 2026 that fell short of analyst expectations.
Read moreScanSource (NASDAQ:SCSC) reported quarterly earnings results on August 20, 2026 that exceeded analyst expectations.
Read moreRoss Stores (NASDAQ:ROST) reported quarterly earnings results on August 20, 2026 that exceeded analyst expectations.
Read moreOSI Systems (NASDAQ:OSIS) reported quarterly earnings results on August 20, 2026 that exceeded analyst expectations.
Read moreHovnanian Enterprises (NYSE:HOV) reported quarterly earnings results on August 20, 2026 that fell short of analyst expectations.
Read moreFlowers Foods (NYSE:FLO) reported quarterly earnings results on August 20, 2026 that fell short of analyst expectations.
Read moreFlux Power Holdings (NASDAQ:FLUX) reported quarterly earnings results on August 20, 2026 that fell short of analyst expectations.
Read moreProspect Capital (NASDAQ:PSEC) reported quarterly earnings results on August 20, 2026 that exceeded analyst expectations.
Read moreSol-Gel Technologies (NASDAQ:SLGL) reported quarterly earnings results on August 20, 2026 that exceeded analyst expectations.
Read moreIVF (NASDAQ:IVF) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read moreForte Biosciences, Inc. (NASDAQ:FBRX) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read moreGaxos.ai Inc. (NASDAQ:GXAI) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read moreT Stamp Inc. (NASDAQ:IDAI) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read moreIndaptus Therapeutics, Inc. (NASDAQ:INDP) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read moreJasper Therapeutics, Inc. (NASDAQ:JSPR) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read morePWCM (NASDAQ:PWCM) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read moreMarker Therapeutics, Inc. (NASDAQ:MRKR) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read moreMotorsport Games Inc. Class A Common Stock (NASDAQ:MSGM) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read moreInnovative Eyewear, Inc. (NASDAQ:LUCY) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Read more